InsidersTradesSigma
Track the WAVE LIFE SCIENCES, INC. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €993.1m. The latest transaction was reported on 13 August 2026 (Cession). Among the most active insiders: Wagner Heidi L. All data is accessible without an account.
Analysts rate WAVE LIFE SCIENCES, INC. Strong Buy (bullish), based on 16 analysts. Average price target: US$19.06.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
WAVE LIFE SCIENCES, INC. is a biopharmaceutical company focused on developing RNA-targeted therapies for genetic diseases. The company is listed on NASDAQ under the ticker symbol WVE.